A systems serology approach to identifying key antibody correlates of protection from cerebral malaria in Malawian children.

Autor: Walker IS; Department of Medicine, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia., Dini S; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, VIC, 3010, Australia., Aitken EH; Department of Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia.; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia., Damelang T; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia., Hasang W; Department of Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia., Alemu A; Department of Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia., Jensen ATR; Centre for Medical Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Rambhatla JS; Department of Medicine, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia.; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia., Opi DH; Department of Medicine, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia.; Burnet Institute, 85 Commercial Road, Melbourne, VIC, 3004, Australia.; Department of Immunology, Monash University, Melbourne, VIC, Australia., Duffy MF; Department of Medicine, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia.; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia., Takashima E; Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Japan., Harawa V; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi., Tsuboi T; Division of Cell-Free Sciences, Proteo-Science Center, Ehime University, Matsuyama, Japan., Simpson JA; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, VIC, 3010, Australia., Mandala W; Academy of Medical Sciences, Malawi University of Science and Technology, Thyolo, Malawi., Taylor TE; Blantyre Malaria Project, Kamuzu University of Health Sciences, Blantyre, Malawi.; College of Osteopathic Medicine, Michigan State University, East Lansing, USA., Seydel KB; Blantyre Malaria Project, Kamuzu University of Health Sciences, Blantyre, Malawi.; College of Osteopathic Medicine, Michigan State University, East Lansing, USA., Chung AW; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia., Rogerson SJ; Department of Medicine, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia. sroger@unimelb.edu.au.; Department of Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia. sroger@unimelb.edu.au.

Publikováno v: BMC medicine [BMC Med] 2024 Sep 12; Vol. 22 (1), pp. 388. Date of Electronic Publication: 2024 Sep 12.

Autoantibodies inhibit Plasmodium falciparum growth and are associated with protection from clinical malaria.

Autor: Hagadorn KA; Malaria Infection Biology and Immunity Section, Laboratory of Immunogenetics, NIAID, NIH, Rockville, MD, USA; Yale School of Public Health, Department of Epidemiology of Microbial Diseases, New Haven, CT, USA., Peterson ME; Malaria Infection Biology and Immunity Section, Laboratory of Immunogenetics, NIAID, NIH, Rockville, MD, USA., Kole H; Autoimmunity and Functional Genomics Section, Laboratory of Immunogenetics, NIAID, NIH, Rockville, MD, USA., Scott B; Autoimmunity and Functional Genomics Section, Laboratory of Immunogenetics, NIAID, NIH, Rockville, MD, USA., Skinner J; Malaria Infection Biology and Immunity Section, Laboratory of Immunogenetics, NIAID, NIH, Rockville, MD, USA., Diouf A; Laboratory of Malaria and Vector Research, NIAID, NIH, Rockville, MD, USA., Takashima E; Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Japan., Ongoiba A; Malaria Research and Training Centre, Department of Epidemiology of Parasitic Diseases, International Center of Excellence in Research, University of Sciences, Technique and Technology of Bamako, Bamako, Mali., Doumbo S; Malaria Research and Training Centre, Department of Epidemiology of Parasitic Diseases, International Center of Excellence in Research, University of Sciences, Technique and Technology of Bamako, Bamako, Mali., Doumtabe D; Malaria Research and Training Centre, Department of Epidemiology of Parasitic Diseases, International Center of Excellence in Research, University of Sciences, Technique and Technology of Bamako, Bamako, Mali., Li S; Malaria Infection Biology and Immunity Section, Laboratory of Immunogenetics, NIAID, NIH, Rockville, MD, USA., Sekar P; Molecular and Cellular Immunology Section, Laboratory of Immunogenetics, NIAID, NIH, Rockville, MD, USA., Yan M; Department of Immunology and Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA., Zhu C; Department of Immunology and Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA., Nagaoka H; Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Japan., Kanoi BN; Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Japan; Centre for Malaria Elimination, Institute of Tropical Medicine, Mount Kenya University, Thika, Kenya., Li QZ; Department of Immunology and Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA; Genecopoeia Inc, Rockville, MD, USA., Long C; Laboratory of Malaria and Vector Research, NIAID, NIH, Rockville, MD, USA., Long EO; Molecular and Cellular Immunology Section, Laboratory of Immunogenetics, NIAID, NIH, Rockville, MD, USA., Kayentao K; Malaria Research and Training Centre, Department of Epidemiology of Parasitic Diseases, International Center of Excellence in Research, University of Sciences, Technique and Technology of Bamako, Bamako, Mali., Jenks SA; Department of Medicine, Division of Rheumatology, Lowance Center for Human Immunology and Emory Autoimmunity Center of Excellence, Emory University, Atlanta, GA, USA., Sanz I; Department of Medicine, Division of Rheumatology, Lowance Center for Human Immunology and Emory Autoimmunity Center of Excellence, Emory University, Atlanta, GA, USA., Tsuboi T; Division of Cell-Free Sciences, Proteo-Science Center, Ehime University, Matsuyama, Japan., Traore B; Malaria Research and Training Centre, Department of Epidemiology of Parasitic Diseases, International Center of Excellence in Research, University of Sciences, Technique and Technology of Bamako, Bamako, Mali., Bolland S; Autoimmunity and Functional Genomics Section, Laboratory of Immunogenetics, NIAID, NIH, Rockville, MD, USA., Miura K; Laboratory of Malaria and Vector Research, NIAID, NIH, Rockville, MD, USA., Crompton PD; Malaria Infection Biology and Immunity Section, Laboratory of Immunogenetics, NIAID, NIH, Rockville, MD, USA. Electronic address: pcrompton@niaid.nih.gov., Hopp CS; Malaria Infection Biology and Immunity Section, Laboratory of Immunogenetics, NIAID, NIH, Rockville, MD, USA; Protozoa Immunology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany. Electronic address: christine.hopp@bnitm.de.

Publikováno v: Immunity [Immunity] 2024 Aug 13; Vol. 57 (8), pp. 1769-1779.e4. Date of Electronic Publication: 2024 Jun 19.

Author Correction: A Pvs25 mRNA vaccine induces complete and durable transmission-blocking immunity to Plasmodium vivax.

Autor: Kunkeaw N; Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Nguitragool W; Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.; Department of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Takashima E; Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Japan., Kangwanrangsan N; Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand., Muramatsu H; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Tachibana M; Division of Molecular Parasitology, Proteo-Science Center, Ehime University, Toon, Japan., Ishino T; Department of Parasitology and Tropical Medicine, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan., Lin PJC; Acuitas Therapeutics, Vancouver, BC, V6T 1Z3, Canada., Tam YK; Acuitas Therapeutics, Vancouver, BC, V6T 1Z3, Canada., Pichyangkul S; Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Tsuboi T; Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Japan., Pardi N; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. pnorbert@pennmedicine.upenn.edu., Sattabongkot J; Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. jetsumon.pra@mahidol.ac.th.

Publikováno v: NPJ vaccines [NPJ Vaccines] 2024 Feb 19; Vol. 9 (1), pp. 36. Date of Electronic Publication: 2024 Feb 19.

The Need for Novel Asexual Blood-Stage Malaria Vaccine Candidates for Plasmodium falciparum .

Autor: Takashima E; Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama 790-8577, Japan., Otsuki H; Division of Medical Zoology, Department of Microbiology and Immunology, Faculty of Medicine, Tottori University, Yonago 683-8503, Japan., Morita M; Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama 790-8577, Japan., Ito D; Division of Medical Zoology, Department of Microbiology and Immunology, Faculty of Medicine, Tottori University, Yonago 683-8503, Japan., Nagaoka H; Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama 790-8577, Japan., Yuguchi T; Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama 790-8577, Japan., Hassan I; Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama 790-8577, Japan., Tsuboi T; Division of Cell-Free Sciences, Proteo-Science Center, Ehime University, Matsuyama 790-8577, Japan.

Publikováno v: Biomolecules [Biomolecules] 2024 Jan 12; Vol. 14 (1). Date of Electronic Publication: 2024 Jan 12.

Pfs230 Domain 7 is targeted by a potent malaria transmission-blocking monoclonal antibody.

Autor: Inklaar MR; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands., de Jong RM; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands., Bekkering ET; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands., Nagaoka H; Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Japan., Fennemann FL; Department of Tumor Immunology, Radboud University Medical Center, Nijmegen, The Netherlands., Teelen K; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands., van de Vegte-Bolmer M; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands., van Gemert GJ; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands., Stoter R; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands., King CR; Center for Vaccine Innovation and Access, PATH, Washington, DC, USA., Proellochs NI; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands., Bousema T; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands., Takashima E; Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Japan., Tsuboi T; Division of Cell-Free Sciences, Proteo-Science Center, Ehime University, Matsuyama, Japan., Jore MM; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands. Matthijs.Jore@radboudumc.nl.

Publikováno v: NPJ vaccines [NPJ Vaccines] 2023 Dec 12; Vol. 8 (1), pp. 186. Date of Electronic Publication: 2023 Dec 12.